Full Text
PCN78 The Cost-Effectiveness of Temozolomide in the Adjuvant Treatment of Newly Diagnosed Glioblastoma in the United States

Abstract

Authors

A. Messali J. Hay R. Villacorta

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×